http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2004409-A6

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c91bbf0395db010b4806f50d808c4e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 1987-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cb3729b65365bcb045a0eea5415c2ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9578743258909380b7d192f83c1819d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8840a9413aa37b080a9b5c56f2f57479
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ecdadfa07c7c4bb25f107f41091f69d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31591a54e738e308c8cbbbadccee64d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91808a6ad719a10e2605dee938ecdfbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40c8eb5e701e4b702e8c83a1be929cd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c1919492ac411abd4740b2be1239e36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e6cce3e4af81a1e51af4e530e70409b
publicationDate 1989-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2004409-A6
titleOfInvention PROCEDURE FOR THE PREPARATION OF NEW PIPERAZIN DERIVATIVES 1,4-DISSTITUTED
abstract THE INVENTION IS RELATED TO NEW PIPERAZINE DERIVATIVES 1,4-DISSTITUTED IN A GENERAL FORMULA (I), WITH ADDITIONAL SALTS OF PHARMACEUTICALLY ACCEPTABLE ACIDS, WITH THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND WITH A PREPARATION PROCEDURE. AND R2 ARE THE SAME OR DIFFERENT AND REPRESENT HYDROGEN OR HALOGEN OR A GROUP OF LOWER ALKYL, TRIHALOMETYL OR LOWER ALKOXYL.
priorityDate 1986-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4742671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426048408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783

Total number of triples: 33.